Found 68 matching trials
Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer
N/AThis is a feasibility study evaluating the use of a mathematical model to p...
Location
University of New Mexico Comprehensive Cancer Center
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
PHASE2This multi-center, open-label, phase II randomized controlled trial is to e...
Location
Sun Yat-sen Memorial Hospital
DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer
PHASE2Our study is a prospective, non-inferior, randomized phase II clinical tria...
Location
Multiple Locations
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)
PHASE3This is a Phase III, multicenter, randomized, placebo-controlled trial desi...
Location
Multiple Locations
Neoadjuvant Treatment of Breast Cancer
N/AObservational investigation of participants who are given neoadjuvant treat...
Location
National Institute of Oncolgy
Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer
PHASE2This is an open-label, multicenter international trial in men and women wit...
Status
Active Not Recruiting
Location
Sainte Catherine - Institut du Cancer Avignon Provence
TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast Cancer
PHASE3Some sub-analysis has shown anthracycline-based regimens are not effective ...
Location
Peking Union Medical College Hospital
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
PHASE2The goal of this clinical trial is to compare trastuzumab deruxtecan (T-DXd...
Location
Skåne University Hospital
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
PHASE2The purpose of this study is to establish a prospective, single-center plat...
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer
PHASE3This was an open-label, randomized controlled trial that aims to compare th...
Location
Cancer Hospital/ Institute, Fudan University